Latest Breaking News On - Prnewswire neurosense therapeutics ltd - Page 1 : comparemela.com

NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients

NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJeremym shefnerBarrow neurological instituteDrug administrationNeurosense therapeutics ltdEuropean medicines agencyPrnewswire neurosense therapeutics ltdEuropean network for the cureSense therapeuticsConfidence intervalEuropean networkRisk factorSeeing primecRating scale revisedInvestigator initiated trial

NeuroSense to Present PARADIGM Data at the American Academy of Neurology Annual Meeting April 16, 2024

NeuroSense to Present PARADIGM Data at the American Academy of Neurology Annual Meeting April 16, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomColorado convention centerPrnewswire neurosense therapeutics ltdAmerican academy of neurology annual meetingExchange commissionNeurosense therapeutics ltdEmerging scienceLate breaker equivalentTime highlights phaseSense therapeuticsMassachusetts general hospitalDorn professorHarvard medical schoolLate breakerAmerican academy

NeuroSense Announces Pricing of $4 5 Million Registered Direct Offering and Concurrent Private Placement

/PRNewswire/ NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense" or the "Company"), a company developing novel treatments for severe neurodegenerative.

United kingdomUnited statesNew yorkExchange commissionPrnewswire neurosense therapeutics ltdA gp alliance global partnersSense therapeuticsAlliance global partnersSecurities act

NeuroSense Announces Pricing of $4 5 Million Registered Direct Offering and Concurrent Private Placement

NeuroSense Announces Pricing of $4 5 Million Registered Direct Offering and Concurrent Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNew yorkPrnewswire neurosense therapeutics ltdA gp alliance global partnersExchange commissionSense therapeuticsAlliance global partnersSecurities actAnnual report

NeuroSense Announces Pricing of $4 5 Million Registered Direct Offering and Concurrent Private Placement

United statesUnited kingdomNew yorkA gp alliance global partnersPrnewswire neurosense therapeutics ltdExchange commissionSense therapeuticsAlliance global partnersSecurities actAnnual report